Edgar Rangel‐López
Impact in
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
- Pharmacology top 5%
- Cannabis and Cannabinoid Research
Papers in
- Pharmacology 14
- Cannabis and Cannabinoid Research 13
- Co-authors
- Abel Santamarı́a (35 shared papers)Ana Laura Colín-González (10 shared papers)Benjamín Pineda (9 shared papers)Julio Sotelo (8 shared papers)Norma Hernández‐Pedro (6 shared papers)Isaac Túnez (16 shared papers)Michael Aschner (16 shared papers)Verónica Pérez de la Cruz (6 shared papers)
- Journals
- Neurotoxicity Research (13 papers)Neuroscience (4 papers)Journal of Cancer Research and Clinical Oncology (2 papers)Pharmaceuticals (2 papers)CNS & Neurological Disorders - Drug Targets (2 papers)
- Partner nations
- MexicoUnited StatesSpain
In The Last Decade
Edgar Rangel‐López
54 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 118
- Biological Psychiatry 55
- Pharmacology 201
- Aging 19
- Parasitology 46
- Cellular and Molecular Neuroscience 128
Countries citing papers authored by Edgar Rangel‐López
This map shows the geographic impact of Edgar Rangel‐López's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgar Rangel‐López with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgar Rangel‐López more than expected).
Fields of papers citing papers by Edgar Rangel‐López
This network shows the impact of papers produced by Edgar Rangel‐López. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgar Rangel‐López. The network helps show where Edgar Rangel‐López may publish in the future.
Co-authors
The 25 scholars most cited alongside Edgar Rangel‐López, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 121 | |
| 2 | 2013 | 70 | |
| 3 | 2017 | 68 | |
| 4 | 1992 | 66 | |
| 5 | 2014 | 47 | |
| 6 | 2012 | 34 | |
| 7 | 2017 | 34 | |
| 8 | 2022 | 31 | |
| 9 | 2023 | 30 | |
| 10 | 2020 | 29 | |
| 11 | 2013 | 28 | |
| 12 | 2019 | 27 | |
| 13 | 2018 | 27 | |
| 14 | 2011 | 25 | |
| 15 | 2019 | 25 | |
| 16 | 2018 | 23 | |
| 17 | 2007 | 22 | |
| 18 | 2013 | 20 | |
| 19 | 2014 | 20 | |
| 20 | Neuroprotective effect of WIN55,212-2 against 3-nitropropionic acid-induced toxicity in the rat brain: involvement of CB1 and NMDA receptors. | 2017 | 20 |
About Edgar Rangel‐López
Edgar Rangel‐López is a scholar working on Pharmacology, Molecular Biology, Biological Psychiatry, Physiology and Cellular and Molecular Neuroscience, having authored 55 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (13 papers), Tryptophan and brain disorders (10 papers), Neuroscience and Neuropharmacology Research (7 papers), Biochemical effects in animals (6 papers), Selenium in Biological Systems (3 papers), Thallium and Germanium Studies (3 papers), Alzheimer's disease research and treatments (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). The work is most often cited by research in Biological Psychiatry (55 citations), Pharmacology (201 citations), Aging (19 citations), Parasitology (46 citations) and Cellular and Molecular Neuroscience (128 citations). Edgar Rangel‐López has collaborated with scholars based in Mexico, United States and Spain. Frequent co-authors include Abel Santamarı́a, Ana Laura Colín-González, Benjamín Pineda, Julio Sotelo, Norma Hernández‐Pedro, Isaac Túnez, Michael Aschner, Verónica Pérez de la Cruz, Anahí Chavarría and Blanca Segura‐Pacheco. Their work appears in journals such as Neurotoxicity Research, Neuroscience, Journal of Cancer Research and Clinical Oncology, Pharmaceuticals and CNS & Neurological Disorders - Drug Targets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.